These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25562120)

  • 1. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.
    Rasmussen NS; Draborg AH; Nielsen CT; Jacobsen S; Houen G
    Scand J Rheumatol; 2015; 44(2):143-9. PubMed ID: 25562120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
    Draborg AH; Jørgensen JM; Müller H; Nielsen CT; Jacobsen S; Iversen LV; Theander E; Nielsen LP; Houen G; Duus K
    Scand J Rheumatol; 2012 Aug; 41(4):280-9. PubMed ID: 22646970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
    Rasmussen NS; Nielsen CT; Houen G; Jacobsen S
    Lupus; 2016 Dec; 25(14):1567-1576. PubMed ID: 27084029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
    Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus.
    Lau CS; Yuen KY; Chan KH; Wong RW
    Chin Med J (Engl); 1998 Jul; 111(7):660-5. PubMed ID: 11245059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
    Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
    Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
    Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
    Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
    Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
    Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
    Draborg AH; Rasmussen NS; Larsen JL; Jørgensen CS; Sandhu N; Skogstrand K; Jacobsen S; Houen G
    PLoS One; 2018; 13(3):e0193244. PubMed ID: 29499037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus infections and circulating microvesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus.
    Rasmussen NS; Draborg AH; Houen G; Nielsen CT
    Clin Exp Rheumatol; 2022 Jan; 40(1):158-161. PubMed ID: 34874835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS.
    Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M
    Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Antibody Titers to Epstein-Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus.
    Knudsen J; Trier NH; Draborg AH; Nielsen CT; Jacobsen S; Højrup P; Houen G
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
    Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
    Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
    Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.
    Palafox Sánchez CA; Satoh M; Chan EK; Carcamo WC; Muñoz Valle JF; Orozco Barocio G; Oregon Romero E; Navarro Hernández RE; Salazar Páramo M; Cabral Castañeda A; Vázquez Del Mercado M
    Arthritis Res Ther; 2009; 11(1):R27. PubMed ID: 19232124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.